IMpella-Protected cArdiaC Surgery Trial (IMPACT)
NCT: NCT05529654 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this Trial is to demonstrate the safety and effectiveness of the use of Impella 5.5 in high-risk cardiac surgery patients, with the overall aim to evaluate if using Impella 5.5 with SmartAssist (Impella 5.5) peri-operatively improves early hemodynamics, end-organ function and clinical outcomes in patients with severely reduced LV function undergoing cardiac surgery.
Frequently Asked Questions
What is IMpella-Protected cArdiaC Surgery Trial (IMPACT)?
IMpella-Protected cArdiaC Surgery Trial (IMPACT) is a clinical trial registered under NCT05529654. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05529654?
The current status of NCT05529654 (IMpella-Protected cArdiaC Surgery Trial (IMPACT)) is: ACTIVE_NOT_RECRUITING.
When did IMpella-Protected cArdiaC Surgery Trial (IMPACT) start?
IMpella-Protected cArdiaC Surgery Trial (IMPACT) started on 2023-09-21.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.